News

Gen Z is watching boomers unretire and doom spending their money in despair—but seven-figure wealth is entirely achievable, ...
Gen Z is watching boomers unretire and doom spending their money in despair—but seven-figure wealth is entirely achievable, ...
The Senate voted along party lines last night to confirm senior Justice Department official Emil Bove to the 3rd U.S. Circuit ...
These two friends, who were raised little more than an hour apart from each other, first played a junior event together about ...
(Reuters) -Union Pacific said on Tuesday it would buy smaller rival Norfolk Southern in an $85 billion deal to create the first U.S. coast-to-coast freight rail operator and reshape the movement of ...
Operator: Thank you for standing by, and welcome to the Kiniksa Pharmaceutical Second Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, today ...
BankUnited’s second quarter results slightly surpassed Wall Street’s revenue and profit expectations, driven by growth in non ...
Happy Wednesday! Lenskart has filed its draft IPO papers for a Rs 8,000-crore public offering. This and more in todays ETtech ...
The Federal Reserve kept the policy rate unchanged at 4.25%-4.50% following the July meeting. The news fell short of impressive, leading to some modest price action. Chairman Jerome Powell's press ...
Discover Criteo S.A.'s Q2 2025 earnings insights: raised guidance, strategic AI progress, expanded partnerships, and growth in Retail & Performance Media.
Ionis Pharmaceuticals Q2 2025 earnings highlight strong Tryngolza sales, increased 2025 revenue guidance, and upcoming Donidalorsen FDA approval.